IHS Chemical Week

Regions :: Western Europe :: Switzerland

Lonza Licenses Biotech to Roche

1:38 PM MDT | January 10, 2007 | Chemical Week Editorial Staff

Lonza says it has agreed to license its glutamine synthetase (GS) expression system and GS-CHO protein free system to Roche for the manufacture of therapeutic recombinant proteins and monoclonal antibodies. Financial terms were not disclosed. The agreement builds on a supply agreement between Lonza and Roche for undisclosed...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa